Retatrutide 30mg Premixed Pen Overview
Retatrutide 30mg Premixed Pen is a cutting-edge, high-purity synthetic peptide designed as a triple receptor agonist. Unlike traditional dual-agonists, Retatrutide targets three critical metabolic pathways: GLP-1, GIP, and Glucagon receptors.
At Wholesale Peptides, our Retatrutide 30mg is synthesized using advanced Solid-Phase Peptide Synthesis (SPPS) and is rigorously validated through HPLC (High-Performance Liquid Chromatography) and Mass Spectrometry (MS). This ensures a purity level of 99.45%+, providing the consistency and reliability required for advanced metabolic research.
Retatrutide Premixed Pen Calculation:
One pen contains 300 units of 100 micrograms.
(1 unit equals 1 division on the doser)
Examples of calculated units per pen of Retatrutide (30mg) corresponding to micrograms:
- 1 unit = 100 mcg
- 4 units = 400 mcg
- 6 units = 600 mcg
- 8 units = 800 mcg
- 10 units = 1 mg
What is Retatrutide 30mg Premixed Pen (LY3437943)?
Retatrutide (research code LY3437943) represents the next generation of metabolic signaling research. By simultaneously activating three distinct hormonal pathways, it offers a synergistic mechanism of action:
- GLP-1 (Glucagon-Like Peptide-1): Promotes glucose-dependent insulin secretion and satiety.
- GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances insulin response and supports lipid metabolism.
- Glucagon Receptor: Increases energy expenditure and promotes hepatic fat oxidation.
This "Triple G" agonist approach makes Retatrutide a primary focus for studies involving energy balance and intensive metabolic regulation.
